Skip to main content

Table 2 Clinical and laboratory characteristics of survivors and non-survivors at 28 days

From: Impact of non-dialysis chronic kidney disease on survival in patients with septic shock

  Survivors Non-survivors p
n=70 n=93
Male gender 44 (63%) 49 (53%) 0.2
Age (years) 64 (53–74) 71 (59–77) 0.01
Diabetes 23 (33%) 28 (30%) 0.9
HBP 39 (56%) 58 (62%) 0.4
Heart failure 9 (13%) 17 (18%) 0.4
Peripheral artery disease 12 (17%) 13 (14%) 0.8
Coronary artery disease 11 (16%) 17 (18%) 0.8
COPD 15 (21%) 12 (13%) 0.2
Statin use 18 (26%) 23 (25%) 0.9
Baseline eGFR (ml/min/1.73m2) 78 (61–106) 63 (38–82) 0.001
CKD 17 (24%) 39 (42%) 0.03
Scr on admission (μmol/l) 209 (122–409) 290 (175–426) 0.15
Scr at onset of septic shock (μmol/l) 232 (117–384) 270 (174–396) 0.2
Hb on admission (g/dl) 10.5 (8.2-12.7) 10 (8.8-11.7) 0.4
SAPS II 50 (40–62) 68 (56–90) <0.001
Days w/o catechol (days) 8 (3–14) 0 (0–2) <0.001
Days w/o MV (days) 5 (2–8) 0 (0–1) <0.001
Length of stay, days 12 (6–25) 4 (1–10) <0.001
RIFLE Classification 59 (44%) 76 (56%) 0.08
  Risk 14 (56%) 11 (44%) 0.7
  Injury 14 (54%) 12 (46%) 0.8
  Failure 27 (35%) 51 (65%) 0.009
  Loss of function 4 (67%) 2 (33%) 0.7
  ESKD - - -
  1. Reported as the number (%) or the median (IQR).
  2. Scr serum creatinine, CKD chronic kidney disease (Baseline eGFR < 60ml/min/1.73m2), BMI body mass index, HBP High blood pressure, SAPS II Simplified Acute Physiologic Score II, adm. admission, GFR glomerular filtration rate, MV mechanical ventilation, catechol. catecholamines.